Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer

Lung Cancer

Volumn 54, Issue 2, 2006, Pages 243-245

  Maitland, Michael L ^a   Wilcox, Rebecca ^a   Hogarth, D Kyle ^a   Desai, Apurva A ^a   Caligiuri, Phil ^a   Abrahams, Cyril ^a   Salgia, Ravi ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Antineoplastic agents; Camptothecins; Case reports; Interstitial; Lung diseases; Lung neoplasms; Pulmonary fibrosis; Small cell lung cancer; Topotecan

Indexed keywords

CAMPTOTHECIN; CARBOPLATIN; ETOPOSIDE; HEPARIN; METHYLPREDNISOLONE; PREDNISONE; PROPOFOL; STEROID; TOPOTECAN;

ADULT; ARTICLE; CASE REPORT; DYSPNEA; HUMAN; HUMAN TISSUE; INTERSTITIAL LUNG DISEASE; LOW BACK PAIN; LUNG DIFFUSION; LUNG FIBROSIS; LUNG INJURY; LUNG SMALL CELL CANCER; MALE; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; SPINAL CORD METASTASIS; TACHYPNEA; THROMBOSIS;

ANTINEOPLASTIC AGENTS; CARCINOMA, SMALL CELL; DYSPNEA; FATAL OUTCOME; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PULMONARY ALVEOLI; PULMONARY FIBROSIS; RESPIRATORY INSUFFICIENCY; TOPOTECAN;

EID: 33751109772     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.07.017     Document Type: Article

References (5)

1. Martinez F.J., Safrin S., Weycker D., Starko K.M., Bradford W.Z., King Jr. T.E., et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 142 (2005) 963-967
2. Edgerton C.C., Gilman M., and Roth B.J. Topotecan-induced bronchiolitis. S Med J 97 (2004) 699-701
3. Erasmus J.J., McAdams H.P., and Rossi S.E. High-resolution CT of drug-induced lung disease. Radiol Clin N Am 40 (2002) 61-72
4. Rossi S.E., Erasmus J.J., McAdams H.P., Sporn T.A., and Goodman P.C. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 20 (2000) 1245-1259
5. Masuda N., Fukuoka M., Kusunoki Y., Matsui K., Takifuji N., Kudoh S., et al. CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer. J Clin Oncol 10 (1992) 1225-1229